Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label adalimumab study in active ankylosing spondylitis after failure of standard therapy or prior TNF inhibitor therapy
2005-004826-21Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in ankylosing spondylitis (AS), sponsored by Abbott Laboratories. Started Nov 2005; status: completed.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2005-004826-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004826-21.